TREATMENT OF OCULAR HYPERTENSION WITH ORAL BETA‐ADRENERGIC BLOCKING AGENTS
Authors:
- 1 August 1974
- journal article
- Published by Wiley in Acta Ophthalmologica
- Vol. 52 (4) , 464-467
Abstract
Propranolol, a β‐adrenergic blocking agent, was given by mouth to 22 patients with elevated IOP resistent to conventional medical treatment or where conventional treatment was contraindicated. A lasting reduction of IOP was obtained in 11 cases; open‐angle glaucoma or elevated IOP responded best. No significant side‐effects were observed. Having in mind the contraindications of β‐adrenergic blocking agents, propranolol can be usefully employed in ophthalmology for controlling elevated IOP.Keywords
This publication has 6 references indexed in Scilit:
- CLINICAL EXPERIENCE WITH PROPRANOLOL IN THE TREATMENT OF GLAUCOMAActa Ophthalmologica, 1973
- Recent Experimental, Clinical, and Therapeutic Research on the Problems of Intraocular Pressure and GlaucomaAmerican Journal of Ophthalmology, 1972
- Intraocularer Druck und Kammerwasserzirkulations-Untersuchungen an Kaninchenaugen nach intravenöser Verabreichung von Propranolol (Inderal®)Graefe's Archive for Clinical and Experimental Ophthalmology, 1972
- Effects of norepinephrine, isoproterenol and sympathetic stimulation on aqueous humour dynamics in vervet monkeysExperimental Eye Research, 1970
- Clinical pharmacology of beta‐receptor‐blocking drugsClinical Pharmacology & Therapeutics, 1969
- Propranolol as ocular hypotensive agent.British Journal of Ophthalmology, 1967